Premeds can get an edge by being published several ways, from hypothesis-based research papers to conference abstracts.

Tvardi Therapeutics, Inc. ("Tvardi") , a clinical-stage biopharmaceutical company focused on the development of novel, oral, small molecule therapies targeting STAT3 to treat fibrosis-driven diseases, ...

Canva Code is one of the newest features Canva is rolling out and I have to say, I find it genuinely helpful. With Canva Code ...

Getting published looks good on your medical school application and indicates that you can dig deep into research and follow through. It can also boost your residency and fellowship applications ...

Mecbotamab vedotin (Mec-V; CAB-AXL-ADC) continues to demonstrate exceptional overall survival (OS) with a 2-year landmark ...

May 13-15: Clinical Trial Supply Forum 2025. Kimi Oanh Le, Head of Clinical Trial Supply at Immunic, will discuss the clinical trial supply chain challenges working across the Middle East and North ...

First-in-class examples of direct SHOC2 binders and modulators of SMP complex assembly identified with potential to block oncogenic RAS/MAPK pathway signaling SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE ...

Genialis, the RNA biomarker company, today announced two new studies demonstrating how predictive algorithms can drive better outcomes for patients, providers, and drug developers. In poster ...

Fulcrum Therapeutics, Inc. ( NASDAQ: FULC) Q1 2025 Earnings Conference Call May 1, 2025 8:00 AM ET Alex Sapir – President and Chief Executive Officer Alan Musso – Chief Financial Officer Iain Fraser – ...

Conference Abstract ... and modeling of swine diseases: the example of PRRS and PED within the Disease Bioportal. Proceedings from Allen D. Leman Swine Conference, Saint Paul, MN, Sep 13-16. Poster ...

However, formal publication in a journal and release of full presentation slides or poster is prohibited until 7:00 ... ASCO's stated preferences and illustrated by the sample press release, the ...